Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Inivata Ltd.
RaDaR, a test for head and neck squamous cell carcinoma, demonstrated high efficacy in a new study.
The partnership with the Princess Margaret Cancer Center will support two studies of liquid biopsy testing for lung cancer.
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.